ABSTRACT Neurophysins are "carrier proteins" associated with vasopressin and oxytocin in the neurohypophyseal system. The release of these hormone associated proteins may serve as an indicator of posterior pituitary function. This report describes the measurement of neurophysin in human and monkey plasma and cerebrospinal fluid (CSF) by radioimmunoassay. Tissue neurophysin is also localized in monkey brain by the immunoperoxidase technique. CSF from 68 patients and five monkeys had easily measurable neurophysin in every sample. The concentration of neurophysin in CSF and in plasma of man is 5.4±0.30 ng/ml (mean and SEM) and 0.69+0.04, respectively. The two means were significantly different (P < 0.001). In paired plasma and CSF specimens which were obtained simultaneously from each of 13 human and five monkey donors, the concentrations of neurophysin in CSF were greater than those of plasma in every case (paired t test, P <0.001). Neurophysin administered intravenously to dogs did not enter CSF. Using the immunoperoxidase technique, we found neurophysin not only in the supraoptic and paraventricular nuclei, their tracts, and the posterior pituitary, but also in the specialized ependymal tanycytes of the infundibular recess of the third ventricle and in the external layer of the median eminence where capillaries drain into hypophyseal portal vessels. Neurophysin may pass from CSF to portal vessels via tanycytes in a manner similar to that postulated for releasing factors.
INTRODUCTION
Nenroplhysins are proteins synthesized in the supraoptic and paraventricular nuclei of the hypothalamus in association with the octapeptide hormones, vasopressin and oxytocin (1, 2) . Neurophysins are thought to be "carrier Dr. Zimmerman is the recipient of Teacher-Investigator Award NS 11,008 from the National Institute of Neurological Diseases and Stroke.
Received for publication 16 October 1972 and in revised form 12 January 1973. proteins" for these peptide hormones, and recent evidence obtained in cows, pigs, rats, goats, and man (3) (4) (5) (6) (7) has confirmed earlier suggestions that neurophysins may be released into the bloodstream in association with oxytocin and vasopressin. Anatomic studies have indicated that there may be one neurophysin for oxytocin and another for vasopressin (8, 9) . However, such an association may not be absolute as indicated by the existence of a third neurophysin in some animals (10, 11) and by limited physiologic data in the cow (3) . Nonetheless, a study of neurophysin localization in hypothalamic tissue and neurophysin secretion may provide new insight into the function of the neurohypophyseal system.
Controversy about the secretion of neurohypophyseal hormones into cerebrospinal fluid (CSF),' as recently reviewed by Heller (12) , has prompted a search for neurophysin in CSF. Data derived by bioassays has produced conflicting results on the presence of oxytocin and vasopressin in CSF. Although early investigators found oxytocic and antidiuretic activities in CSF, these findings were later discounted when Van Dyke (13) drew attention to ionic and other properties of CSF that might lead to artifactual results. However, recent studies using improved bioassays indicated that vasopressin and oxytocin are present in spinal fluid (14) (15) (16) praoptic and paraventricular tracts, and axonal terminals in the infundibular process (17) . Microscopic studies using less specific staining have suggested an association of the paraventricular and supraoptic neurons with the ependymal lining surface of the third ventricle and, therefore, CSF (18) (19) (20) (21) (22) . In the present study we have localized neurophysin in the specialized ependymal tanycytes of the ventral portion of the third ventricle at the level of the median eminence.
METHODS
Preparation of bovine neurophysin has been previously described, and the radioimmunoassay procedure for neurophysin has been detailed (23) . Human and monkey neurophysin was measured by a similar radioimmunoassay using human neurophysin I provided by Doctors Cheng and Friesen and described elsewhere (24) . Human neurophysin is used as both the radioactive tracer and the unlabeled neurophysin of the standard curve. Antiserum to bovine neurophysin I is utilized in the human and monkey assays at a dilution of 1-2000. 25 pg of human neurophysin causes a 10% reduction in the binding of radiolabeled neurophysin. Using 50 Ml of plasma or CSF, we find that the assay readily measures neurophysin at concentrations as low as 0.5-0.6 ng/ml. Human neurophysin I and II give parallel standard curves in this system using anti-bovine neurophysin I. Bovine neurophysin I and II also react with identity in this assay. All human and monkey neurophysin values reported here are a measure of "total" neurophysin with no distinction between different neurophysins. 50 Ml of normal human plasma from a well-hydrated male is added to each tube of the standard curve and to the CSF assay tubes to negate the effects of protein in comparing plasma with the standard curve or CSF with plasma. When 50 ul of this normal human plasma is compared with a standard curve run in buffer alone, less than 0.6 ng/ml neurophysin is measured in the normal plasma. All samples were run at two dilutions and in duplicate or triplicate. Monkey neurophysin in plasma and CSF reacted identically with human neurophysin in this assay and is expressed in terms of the human neurophysin standard.
Human CSF and plasma was obtained following lumbar puncture during routine diagnostic procedures. Local lumbar anesthesia was used. CSF and plasma was obtained from five normal female Rhesus monkeys at various times of the menstrual cycle. CSF was obtained by cisternal or lumbar puncture in monkeys under phencyclidine tranquilization. The studies involving dogs were conducted in mongrel animals anesthetized with intravenously-administered pentobarbital. 60 min after induction of anesthesia, the dogs were injected intravenously with 375 ug of a crude bovine neurophysin or with 50-100 yg of purified bovine neurophysin I, and several plasma samples were taken over the next 75-105 min. CSF was obtained by cisternal puncture. Unlike the human and monkey samples, the canine CSF and plasma samples were assayed by a specific bovine neurophysin I assay. This assay uses bovine neurophysin I and anti-neurophysin I at a dilution of 1:35,000 (23) . At this antibody dilution the injected bovine neurophysin is measured while the dogs' own neurophysin is not detectable. Other dogs studied in the same way were injected with 10 ml of 0.15 M NaCl rather than neurophysin. These animals served as controls.
Column chromatography of concentrated CSF specimens was done on G-75 Sephadex columns (1 X 25 cm), and the elution patterns were compared with that of Mi-labeled human neurophysin I. Protein determinations were done by the Folin method of Lowry, Rosenbrough, Farr, and Randall (25) .
Cross-sections of paraffin-embedded hypothalamic tissue from two adult female Rhesus monkeys (M210, M212) were prepared and stained by an immunoperoxidase technique as previously reported (17) . The brain of M210 was prepared on day 14 of the menstrual cycle using perfusion fixation with 10% buffered formalin whereas M212 was prepared on day 35 of the menstrual cycle by immersion fixation in Bouin's solution. 5-,gm paraffin sections on glass slides were deparaffinized, rehydrated in 0.01 M pH 7.2 phosphate-buffered saline (PBS), and reacted in a threelayer immunoperoxidase bridge system to localize the antigenic tissue sites of neurophysin (26, 27) . Rabbit antiserum to bovine neurophysin I (1:100) was first applied to the tissue sections as the specific antibody and incubated in a moist chamber for 30 min. After washing for 10 min in PBS, ovine antiserum to rabbit globulin and rabbit antiserum to horseradish peroxidase were sequentially applied in a similar fashion for 30 min each, followed by incubation with horseradish peroxidase (0.5 mg/ml) 2 for 20 min. 10-min washes in PBS were made between each step. The slides in which horseradish peroxidase was attached to antibody sites were reacted with 3,3' diaminobenzidene (75 mg/ ml) with 0.003% hydrogen peroxide for 20 min to produce a brown color. Control experiments were performed by replacing specific rabbit antiserum to bovine neurophysin I with normal rabbit serum and with rabbit antiserum to bovine neurophysin I preabsorbed with bovine neurophysin I.
RESULTS
Similarity of pituitary and CSF neurophysin. The identity of CSF with pituitary neurophysin was established by column chromatography and by specific radioimmunoassay. The characteristic elution pattern of ['l] human neurophysin from a column of G-75 Sephadex (1 X 20 cm) is shown in the top graph of Fig. 1 . 10 ml of CSF from three patients was lyophilized to dryness and redissolved in 1 ml of distilled water. The reconstituted CSF was applied to a Sephadex column and eluted with 0.05 M phosphate buffer. The neurophysin content of the eluate was determined by radioimmunoassay. The elution pattern for CSF neurophysin was similar to ["SI] pituitary neurophysin ( Fig. 1 , lower graph, line A). Line B is a similar elution pattern of CSF neurophysin prepared from 10 ml of spinal fluid from two patients. Again, the similarity between the elution of CSF neurophysin and pituitary neurophysin is noted. Of the total protein added to the columns 88% was eluted before and 8% after the neurophysin peaks. The salt peaks were eluted after the neurophysin. Each neurophysin peak containing 6% of the CSF protein and none of the CSF electrolytes was pooled and concentrated by ultrafiltration for further studies. 2 (Fig. 3) . In every case, the neurophysin concentration in CSF was greater than the neurophysin concentration in plasma from the same donor. The differences were highly significant (P < 0.001 by the paired t test). (Cisternal and lumbar CSF neurophysin concentrations were not significantly different.)
Source of neurophysin in CSF. As neurophysin is known to be secreted into plasma the transfer of neurophysin from plasma to CSF was investigated in mongrel dogs injected intravenously with bovine neurophysin. (Bovine neurophysin was used because it is available in greater quantity and can be specifically measured by radioimmunoassay.) We were able to follow the injected protein independent of any changes in the dogs' own neurophysin. During the control period of 60 min, plasma neurophysin was immeasurable in all animals. In two dogs injected with a bolus of 0.15 M NaCl and from which blood samples were taken periodically for 120 min and a CSF specimen at 105 min, neurophvsin was un- (Fig. 4) ;
upper ventricular arrow) and by the absence of staining in control slides when normal rabbit serum or antiserum absorbed with neurophysin I is substituted for the antiserum to neurophysin (Fig. 5) . At higher magnification. the specialized ependymal tanycyte (Fig. 6) shows intense staining in the perikarvon and on the ventricular surface, at times appear- I N '
ing as globular protrusions. The cytoplasmic neurophysin FIGURE 5 Higher magnification of an area corresponding streaks laterally from the perikaryon for a short distance to lower ventricle arrow of Fig. 4 . Control experiment in in the tanycyte process which runs perpendicular to the which antibody to neurophysin is replaced with nonimmune ventricular surface (arrow Fig. 6 ). Neurophysin in the rabbit serum. No neurophysin staining is seen and a faint lateral tanycyte cannot be traced with certainty beyond general background remains. (X 504) that shown in the figure. The tanycytes contrast markedly with the ciliated ependymal cells of the dorsal por-paired plasma and CSF samples were taken from man tions of the third ventricle which show little staining or monkey, the concentration of neurophysin was higher (Fig. 7) and thus presumably contain little neurophysin. in CSF than in plasma. Neurophysin is known to be secreted into plasma, but this finding of higher levels of DISCUSSION neurophysin in CSF suggests that neurophysin is also Our studies demonstrate that neurophysin is present in secreted into CSF. CSF of man and monkey. CSF neurophysin has been
The possibility of neurophysin transfer from plasma concentrated and shown by column chromatography to to CSF was investigated by the infusion of bovine neurohave a molecular weight similar to pituitary neurophy-physin in the dog. The assumption that the bovine neusin. The parallel behavior of CSF neurophysin and pitui-rophysin behaves physiologically like dog neurophysin tary neurophysin in the radioimmunoassay and the ability is justified by the studies of Fawcett, Powell, and Sachs of concentrated CSF neurophysin to inhibit the binding (28) who demonstrated that dog neurophysin possessed of pituitary neurophysin by specific antibodies to neuro-chemical and serologic properties similar to bovine physin demonstrate the immunologic identity of CSF and neurophysin. Furthermore, the studies of Capra, Kehoe, pituitary neurophysin in man.
Kotelchuck, Walter, and Breslow (29) demonstrated the The average concentration of neurophysin in CSF was close amino acid sequence of neurophysins from differunexpectedly much higher than that of plasma. Several ent species, and several investigators (2831) have reports have demonstrated that the vasopressin content pointed out the immunologic cross-reactivity between species. Indeed, our antiserum to bovine neurophysin at low dilution (e.g., 1: 2000 in a radioimmunoassay) binds with neurophysin from other species but does not bind at high dilution (e.g., 1: 35,000). This fact enabled us to discriminate between bovine and canine neurophysins. When bovine neurophysin was injected into dogs in quantities sufficient to cause transient plasma neurophysin values that were 30-100 times the normal resting value (3), virtually no bovine neurophysin appeared in CSF. This was true in the dogs injected with the crude neurophysin preparation as well as in dogs injected with purified bovine neurophysin I. This finding is further indication that the neurophysin present in CSF of monkey and man is the result of secretion of neurophysin into CSF. If neurophysin secretion and hormone secretion are mutually dependent phenomenon, then these data indicate that vasopressin is also secreted into CSF.
The anatomic localization of neurophysin in the monkey extends the observations of Talanti and Kivalo tending to the third ventricle and showed that these fibers separated from the supraoptico-hypophyseal tract which extends to the posterior pituitary. Our findings of neurophysin localization around the infundibular recess indicate that the "neurosecretory material" contains neurophysin. We also found staining where fibers from the supraoptico-hypophyseal tract approach the third ventricle suggesting that this may be a point of secretion of neurophysin into ventricular CSF. The infundibular area where neurophysin is concentrated in the tanycytes is receiving increasing attention by neuroendocrinologists independent of any consideration of vasopressin and oxytocin. Indeed, although there is strong evidence linking neurophysin with vasopressin and oxytocin in the posterior pituitary, it is possible that the secretion of neurophysin into CSF is independent of these hormones.
The tanycytes of the infundibular recess which we have shown to contain neurophysin are of specific anatomic interest. The studies of several investigators (33) (34) (35) (36) (37) (38) suggest that these specialized ependymal cells may play a neuroendocrine role by providing a pathway from the CSF of the third ventricle to the hypothalamic portal system. It has been shown that vasopressin placed in the third ventricle of the dog had a significant effect on adrenocortical steroid output (presumably by stimulating the release of ACTH) whereas 10 times that dose by peripheral vein had no effect (35 (33, 36) have traced the tanycyte processes from the surface of the third ventricle to their termination in close proximity FIGURE 7 Ciliated ependyma of the same section shown in Fig. 6 (area of upper arrow at ventricle, Fig. 4 (36, 37) . Our studies demonstrate the specific presence of neurophysin in the CSF, in the tanycytes of the infundibular recess, in the tanycyte processes, and in the external palisade layer of the median eminence. This area around the third ventricle is the only area adjacent to the ventricular svstem which contains neurophysin, and we propose that fibers of the supraoptico-hypophyseal tract may secrete neurophysin into the CSF at this level. The intense staining of the ventricular surface of the tanycvtes and the identification of neurophysin in the tanycyte processes suggests that these cells may absorb neurophysin from the CSF. This interpretation is most compatible with previous studies of tanycyte function. While our study has not specifically identified neurophysin in the distal terminals of the tanycyte processes, we have localized neurophysin in the external palisade layer of the median eminence where the tanycyte processes are known to abut onto portal vessels. While some neurophysin in this external laver may arrive from axons of the supraopticohypophyseal tract, it is likely that neurophvsin is also present in the terminals of the tanycyte processes.
This paper is the first report of neurophysin in CSF and in areas of the brain separate from the supraoptic and paraventricular nuclei and their classic pathways to the neurohypophysis (20) . The specific presence of neurophysin in CSF and the probability of its direct secretion supports the bioassay reports of vasopressin in spinal fluid. However, the more significant finding may be the localization of neurophysin around the infundibular recess of the third ventricle in the tanycytes, and around portal vessels. This area has been of interest as an alternate pathway for the secretion of anterior pituitary releasing factors (37) . It has been suggested that releasing factors may first be secreted into CSF, reabsorbed by tanycytes, transported by their processes, and resecreted into the portal blood (38) . The radioimmunoassay data on neurophysin in CSF and the anatomic findings are compatible with a similar concept for neurophvsin. ' Whether this is an undescribed pathway of vasopressin and oxytocin secretion and/or whether neurophysin is related to the previous work on releasing factors remains to be determined.
